Search Ontology:
ChEBI
AcGly-Ser(O-L-alpha-D-Hep)-Gly-Leu
- Term ID
- CHEBI:194468
- Synonyms
-
- (2S,8S)-8-[({(2S,3S,4S,5S,6R)-6-[(1R)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl}oxy)methyl]-4,7,10,13-tetraoxo-2-[(propan-2-yl)oxy]-3,6,9,12-tetraazatetradecan-1-oic acid
- (2S,8S)-8-[({(2S,3S,4S,5S,6R)-6-[(1R)-1,2-dihydroxyethyl]-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl}oxy)methyl]-2-isopropoxy-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecan-1-oic acid
- AcGlySer(O-L-alpha-D-Hep)GlyLeu
- N-acetylglycyl-L-seryl(O-L-glycero-alpha-D-manno-heptopyranosyl)glycyl-L-leucine
- Definition
- A derivatised tetrapeptide in which a parent tetrapeptide comprising glycine, L-serine, glycine and L-leucine residues coupled in sequence, has its terminal glycine residue acetylated on nitrogen and its serine residue L-glycero-alpha-D-heptosylated on oxygen.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_functional_parent
-
- has_part
-
Show first 5 Terms
Phenotype
Phenotype resulting from AcGly-Ser(O-L-alpha-D-Hep)-Gly-Leu
Phenotype where environments contain AcGly-Ser(O-L-alpha-D-Hep)-Gly-Leu
Phenotype modified by environments containing AcGly-Ser(O-L-alpha-D-Hep)-Gly-Leu
Human Disease Model